Labcorp Inc.
LH | NYSE
$320.99
+$0.28 (+0.09%)
At close: Sep 21, 2026, 4:00 PM ET
$302.99
-$18 (-5.61%)
Pre-market:
Sep 22, 2026, 8:19 AM ET
Company Profile
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
Key Executives
| Name | Position |
|---|---|
| Adam H. Schechter | President, Chief Executive Officer & Chairman |
| Amy Summy | EVP, Chief Marketing Officer & Consumer Health Lead |
| Julia Wang | Chief Financial Officer & Executive Vice President |
| Kathryn Wright Kyle | Executive Vice President, Chief Legal Officer & Corporate Secretary |
| Akinbolade Oyegunwa | Executive Vice President and Chief Information & Technology Officer |
| Anita Z. Graham | Executive Vice President & Chief Human Resources Officer |
| Brian J. Caveney | EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer |
| Christin O'Donnell | Vice President of Investor Relations |
| Dewey Steadman | Senior Vice President of Investor Relations |
| Jonathan C. Meltzer | EVP & Chief Operations Officer |
| Megan D. Bailey | Executive VP and President of Central Laboratory Services & International Labcorp |
| Peter J. Wilkinson | Senior Vice President & Chief Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Aug 28, 2026 | 8-K | Current Report |
| Aug 18, 2026 | 4 | Filing |
| Aug 17, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 8-K | Current Report |
| Aug 12, 2026 | 4 | Filing |
| Aug 06, 2026 | 4 | Filing |
Labcorp Inc.
| Country | United States |
| IPO Date | Mar 28, 1990 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 71,000 |
| CEO | Adam H. Schechter |
Contact Details
358 South Main Street Burlington,
North Carolina 27215 United States
Stock Details
| Ticker Symbol | LH |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000920148 |
| CUSIP Number | 504922105 |
| ISIN Number | US5049221055 |
| SIC Code | 8071 |
Recent News
- 6 days ago / seekingalpha.comLabcorp Holdings Inc. (LH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- 11 days ago / seekingalpha.comLabcorp Holdings Inc. (LH) Analyst/Investor Day Transcript
- 12 days ago / benzinga.comLabcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029
- 12 days ago / prnewswire.comLabcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
- 13 days ago / prnewswire.comMoonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
- 15 days ago / zacks.comWhy Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
- 20 days ago / zacks.comHere's Why Labcorp Holdings (LH) is a Strong Momentum Stock
- 28 days ago / zacks.comShould You Continue to Hold Labcorp Stock in Your Portfolio?
- 29 days ago / prnewswire.comLabcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings
- 1 month ago / prnewswire.comLabcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health
Add to Watchlist
Select watchlists to add or remove LH